Lilly, Evidation Health and Apple Study Shows Personal Digital Devices May Help in the Identification of Mild Cognitive Impairment and Mild Alzheimer’s Disease Dementia


INDIANAPOLIS, Aug. 8, 2019 /PRNewswire/ — Initial results from a feasibility study conducted by Eli Lilly and Company (LLY), Evidation Health, and Apple Inc. (AAPL) showed that an iPhone, Apple Watch, iPad and the Beddit sleep monitoring device, in combination with digital apps may be able to differentiate people with mild cognitive impairment (MCI) and mild Alzheimer’s disease dementia.1 The exploratory results were presented today at the Association for Computing Machinery’s KDD conference in Anchorage, and are published on the conference website as one of the top papers of the conference. “Over the past few years, we’ve seen how data and insights derived from wearables and mobile consumer devices have enabled people living with health conditions, along with their clinicians, to better monitor their health,” said Nikki Marinsek, Ph.D., a first author and data scientist at Evidation Health.